Spyropoulos AC - Search Results

1

Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis.

Mahan CE, Hussein MA, Amin AN, Spyropoulos AC. Mahan CE, et al. Among authors: spyropoulos ac. Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):45-58. doi: 10.1177/1076029611405186. Epub 2011 Sep 23. Clin Appl Thromb Hemost. 2012. PMID: 21949041 Free article. Clinical Trial.

2

Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin.

Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G. Spyropoulos AC, et al. Chest. 2002 Jul;122(1):108-14. doi: 10.1378/chest.122.1.108. Chest. 2002. PMID: 12114345

3

The clinical thrombosis center and clinical thrombologist: a new US health systems paradigm for the management of venous thromboembolic disease.

Spyropoulos AC, Haire W. Spyropoulos AC, et al. J Thromb Thrombolysis. 2003 Jun;15(3):227-32. doi: 10.1023/B:THRO.0000011378.16223.e4. J Thromb Thrombolysis. 2003. PMID: 14739633

4

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC. Willey VJ, et al. Among authors: spyropoulos ac. Clin Ther. 2004 Jul;26(7):1149-59. doi: 10.1016/s0149-2918(04)90187-7. Clin Ther. 2004. PMID: 15336480

5

Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.

Spyropoulos AC. Spyropoulos AC. Chest. 2005 Aug;128(2):958-69. doi: 10.1378/chest.128.2.958. Chest. 2005. PMID: 16100192 Review.

6

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG. Cohen AT, et al. Among authors: spyropoulos ac. Thromb Haemost. 2005 Oct;94(4):750-9. Thromb Haemost. 2005. PMID: 16270626 Review.

7

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators. Spyropoulos AC, et al. J Thromb Haemost. 2006 Jun;4(6):1246-52. doi: 10.1111/j.1538-7836.2006.01908.x. J Thromb Haemost. 2006. PMID: 16706967 Free article.

8

Pharmacologic therapy for the management of thrombosis: unfractionated heparin or low-molecular-weight heparin?

Spyropoulos AC. Spyropoulos AC. Clin Cornerstone. 2005;7(4):39-48. doi: 10.1016/s1098-3597(05)80102-4. Clin Cornerstone. 2005. PMID: 16758651 Review.

9

Management of venous thromboembolism in the elderly.

Spyropoulos AC, Merli G. Spyropoulos AC, et al. Drugs Aging. 2006;23(8):651-71. doi: 10.2165/00002512-200623080-00003. Drugs Aging. 2006. PMID: 16964988 Review.

10

Prevention of venous thromboembolism: clinical and economic implications. Introduction.

Spyropoulos AC. Spyropoulos AC. Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S3-4. doi: 10.2146/ajhp060387. Am J Health Syst Pharm. 2006. PMID: 17032932 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results